Nicola Evans

Nicola is Chief Executive of the iCMLf, where she provides strategic leadership for the Foundation’s global partnerships, programs, and initiatives aimed at improving the lives of people living with CML. With more than 20 years of experience in the pharmaceutical and healthcare sectors, she brings extensive expertise in leadership, global health, and advancing health equity.

Since joining the iCMLf at its inception in 2009, Nicola has been instrumental in expanding access to best-practice CML treatment and support in low- and middle-income countries, while fostering international collaboration in research, education, and care. She plays a key role in uniting clinicians, researchers, advocates, and industry partners around the shared goal of curing CML and addressing global disparities in treatment and outcomes.